CELOX PRO, CELOX PRO OTC, CELOX HEMOSTATIC GRANULES, CELOX PRO HEMOSTATIC GRANULES, OMNI STAT PRO— 510(k) K093593

Name: FDA 510(k) clearance K093593
Creator: U.S. Food and Drug Administration
Published: 2010-01-20

Substantially Equivalent

Medtrade Products Limited

FDA 510(k) clearance K093593 for CELOX PRO, CELOX PRO OTC, CELOX HEMOSTATIC GRANULES, CELOX PRO HEMOSTATIC GRANULES, OMNI STAT PRO, Substantially Equivalent on 2010-01-20. Applicant: Medtrade Products Limited. Device class: Unclassified.

Clearance details

Applicant: Medtrade Products Limited
Product code: Code QSY
Device class: Unclassified
Advisory panel: Unknown
Date received: 2009-11-19
Decision date: 2010-01-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Crewe, Cheshire, GB

Download summary PDF View on FDA.gov ↗

Recent devices under product code QSY

view all

K253017 — BloodSTOP iX Trauma Matrix (TM-iX-20)2026-04-30
K251700 — Ganymede 2cm diameter (FG100300) +14 more2026-02-26
K250319 — MFUSE (MS001)2025-12-15
K253609 — TRAUMAGEL® 2.0 Hemostatic Gel2025-12-12
K240713 — TRAUMAGEL®2024-08-14

More clearances from Medtrade Products Limited

view all

K100693 — AQUANOVA AG SUPER ABSORBANT DRESSING, AQUANOVA AG ANTIMICROBIAL DRESSING2010-08-10

Adverse events under product code QSY

product code QSY

Death: 5
Other: 1
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.